Agios Pharmaceuticals, Inc. (AGIO): Price and Financial Metrics
Agios Pharmaceuticals, Inc. (AGIO)
Today's Latest Price: $35.50 USD
Updated Oct 20 4:00pm
Add AGIO to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
AGIO Stock Summary
- With a price/sales ratio of 13.12, Agios Pharmaceuticals Inc has a higher such ratio than 88.99% of stocks in our set.
- With a year-over-year growth in debt of 209.35%, Agios Pharmaceuticals Inc's debt growth rate surpasses 92.57% of about US stocks.
- As for revenue growth, note that AGIO's revenue has grown 82.88% over the past 12 months; that beats the revenue growth of 93.72% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to Agios Pharmaceuticals Inc, a group of peers worth examining would be RGNX, SYRS, CNCE, DRNA, and APTX.
- Visit AGIO's SEC page to see the company's official filings. To visit the company's web site, go to www.agios.com.
AGIO Stock Price Chart Interactive Chart >
AGIO Price/Volume Stats
| Current price | $35.50 | 52-week high | $56.74 |
| Prev. close | $35.28 | 52-week low | $27.77 |
| Day low | $35.46 | Volume | 555,100 |
| Day high | $36.07 | Avg. volume | 692,396 |
| 50-day MA | $37.74 | Dividend yield | N/A |
| 200-day MA | $44.71 | Market Cap | 2.45B |
Agios Pharmaceuticals, Inc. (AGIO) Company Bio
Agios Pharmaceuticals is focused on discovering and developing novel investigational medicines to treat cancer and rare genetic disorders of metabolism through scientific leadership in the field of cellular metabolism. The company was founded in 2007 and is based in Cambridge, Massachusetts.
Loading social stream, please wait...